Concord Biotech Limited (MAINBOARD)
Aug 4, 2023 - Aug 8, 2023
| Price | ₹705 - ₹741 |
| Premium | ₹125 |
|---|---|
| Lot size | 20 |
| Allotment | Aug 14, 2023 |
| Listing | Aug 18, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 20 | 14820 | 0 |
| sHNI | 14 | 280 | 207480 | 0 |
| bHNI | 68 | 1360 | 1007760 | 0 |
Last Updated as on 08-Aug-2023 17:54:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 39,79,901 | 28,30,64,540 | 71.12 |
| HNIs | 29,84,926 | 5,33,04,000 | 17.86 |
| HNIs (10+L) | 19,89,951 | 4,03,68,000 | 20.29 |
| HNIs (2-10L) | 9,94,976 | 1,29,36,000 | 13 |
| Retail | 69,64,828 | 2,76,69,940 | 3.97 |
| Employees | 9,514 | 2,44,720 | 25.72 |
| Total | 1,39,39,170 | 36,42,83,200 | 26.13 |
| Category | Retail | sHNI | bHNI |
|---|---|---|---|
| Min Shares | 20 | 280 | 1360 |
| Min Amount | 14820 | 207480 | 1007760 |
| Application Reserved | 366024 | 3735 | 7470 |
| Subject 2 | |||
| FIX | 650 | 1800 | 8000 |
Incorporated in 1984, Concord Biotech Limited is an India-based biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying its offerings to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. They started with a single product and has grown to become a wide spectrum solution provider.
Concord Biotech IPO Details
| Total Issue Size | 20,925,652 shares (aggregating up to ₹[.] Cr) |
| Offer for Sale | 20,925,652 shares of ₹1 (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Concord Biotech IPO Reservation
Company Financials
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31 Mar 2021 | 1,182.55 | 630.75 | 234.89 | 999.37 | 86.35 |
| 31 Mar 2022 | 1,312.80 | 736.35 | 174.93 | 1,103.22 | 60.59 |
| 31 Mar 2023 | 1,513.98 | 888.48 | 240.08 | 1,290.00 | 31.24 |
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: concordbiotech.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html